Taysha Gene Therapies
TSHA
TSHA
148 hedge funds and large institutions have $595M invested in Taysha Gene Therapies in 2025 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 48 increasing their positions, 33 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
45% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 33
38.7% more ownership
Funds ownership: 81.35% → 120.04% (+39%)
18% more funds holding
Funds holding: 125 → 148 (+23)
Holders
148
Holding in Top 10
3
Calls
$465K
Puts
$47K
Top Buyers
| 1 | +$29.3M | |
| 2 | +$28.2M | |
| 3 | +$23.3M | |
| 4 |
RI
RTW Investments
New York
|
+$14.4M |
| 5 |
DM
Deerfield Management
New York
|
+$12.4M |
Top Sellers
| 1 | -$1.8M | |
| 2 | -$1.58M | |
| 3 | -$1.05M | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$726K |
| 5 |
BlackRock
New York
|
-$659K |
